CME webinar: Pediatric Asthma Management Guidelines

Jul. 2022Education/Webinars
"Please join us for a live, CME-accredited webinar Wednesday, Aug. 24, from noon to 1 p.m. The presentation will include an overview of the latest 2020 Pediatric Asthma Management Guidelines, including:

  • The use of as-needed courses of inhaled corticosteroids in the management of mild persistent asthma.
  • The use of single-inhaler maintenance and reliever therapy (SMART) in moderate persistent asthma.
  • Strategies and potential barriers to the implementation of new asthma management guidelines.
  • Sharing UPMC Health Plan asthma resources.


Presenters:

  • Erick Forno, MD, MPH, ATSF, Director, CHP Pediatric Asthma Center Division of Pediatric Pulmonary Medicine at UPMC Children’s Hospital of Pittsburgh/University of Pittsburgh School of Medicine
  • Deborah Moss, MD, MPH, FAAP, Professor of Pediatrics, University of Pittsburgh Children’s Hospital of Pittsburgh of UPMC Division of General Academic Pediatrics; Pediatric Medical Director, UPMC for You; and Medical Director, UPMC for Kids
  • Erin McConnell, PharmD, Program Manager, Pharmacy Quality, UPMC Health Plan


Register now at upmchp.us/asthma. This webinar will be recorded.

You may earn continuing medical education (CME) credits for attending this webinar.*

*This activity is approved for AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Provider is responsible for verifying CME eligibility.
"

Recent Announcements

Watch for a chance to rate your experience with UPMC Health Plan

Watch for a chance to rate your experience with UPMC Health Plan. You may be randomly selected to participate in a 2026 Press Ganey provider satisfaction survey that will begin this month.
Aug. 2026Important Notices

Voluntary nationwide recall: Cetirizine (Unique – July)

Unique Pharmaceutical Laboratories (A Div. of J. B. Chemicals & Pharmaceuticals Ltd.) is recalling four lots (GY825029, GY825030, GY825031, GY825032) of Cetirizine Hydrochloride Tablets USP 5 mg. Cetirizine is used for the relief of allergy symptoms, including itchy, red, watery eyes and itchy skin.
Jul. 2026Pharmacy Updates

August 2026 UPMC for You and UPMC Community HealthChoices Formulary Updates

Effective Aug. 15, 2026, UPMC for You and UPMC Community HealthChoices are updating their formularies.
Jul. 2026Pharmacy Updates